Literature DB >> 28115285

Luhong formula inhibits myocardial fibrosis in a paracrine manner by activating the gp130/JAK2/STAT3 pathway in cardiomyocytes.

Huiyan Qu1, Yong Wang1, Yingjie Wang1, Tao Yang1, Zhou Feng1, Yang Qu1, Hua Zhou2.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Luhong formula (LHF)-a traditional Chinese medicine containing Cervus nippon Temminck, Carthamus tinctorius L., Cinnamomum cassia Presl, Codonopisis pilosula( Franch.) Nannf., Astragalus membranaceus ( Fisch.) Bge. var. mongholicus ( Bge.) Hsiao, Lepidium apetalum Willd-is used in the treatment of heart failure. AIM OF THE STUDY: To investigate the antifibrotic efficacy of LHF in a myocardial infarction-induced rat model of heart failure and to determine its mechanism of action.
MATERIAL AND METHODS: Myocardial infarction was induced in rats by coronary artery ligation, and cardiac fibroblasts were isolated. Neonatal rat cardiomyocytes (NRCMs) were isolated from 2 to 3-day-old Sprague-Dawley male rats, and cardiomyocyte hypertrophy was induced by isoprenaline. Histological examination was carried out to estimate the degree of myocardial fibrosis. Expression of gp130/JAK2/STAT3 pathway proteins was measured by western blot. The mRNA levels of downstream genes of gp130/JAK2/STAT3 pathway (i.e., CTGF, TSP-1, and TIMP1) were determined by RT-PCR; while CTGF, TSP-1, and TIMP1 protein levels were measured by ELISA. To investigate paracrine effects, cell proliferation and collagen synthesis was measured after treating cardiac fibroblasts with the conditioned media from isoprenaline-treated NRCMs.
RESULTS: Histopathological changes showed that LHF inhibited myocardial fibrosis in heart failure rats. Treatment with LHF up-regulated gp130, JAK2, and STAT3 protein expression in heart tissue, and down-regulated CTGF, TSP-1, and TIMP1 gene expression. Isoprenaline-treated NRCMs displayed lower expression of the gp130, JAK2, and STAT3 pathway proteins and higher secretion of its downstream signaling molecules (CTGF, TSP-1, TIMP1). LHF inhibited cardiac fibroblast proliferation and collagen synthesis after treatment with the conditioned media from isoprenaline-treated NRCMs.
CONCLUSION: LHF treatment attenuates myocardial fibrosis in vivo. LHF inhibits cardiac fibroblasts proliferation and collagen synthesis in a paracrine manner by activating the gp130/JAK2/STAT3 pathway in cardiomyocytes, thereby inhibiting the secretion of downstream profibrogenic cytokines.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Cardiovascular system; Cytokines; Fibroblast; Gene expression; Heart failure; Myocardial fibrosis; Myocardial infarction; Proliferation; Signal transduction; Traditional Chinese medicine

Mesh:

Substances:

Year:  2017        PMID: 28115285     DOI: 10.1016/j.jep.2017.01.033

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  8 in total

Review 1.  Endothelial-cell-mediated mechanism of coronary microvascular dysfunction leading to heart failure with preserved ejection fraction.

Authors:  Yong Wang; Juan Zhang; Zhen Wang; Cheng Wang; Dufang Ma
Journal:  Heart Fail Rev       Date:  2022-03-09       Impact factor: 4.214

2.  Two Sulfur Glycoside Compounds Isolated from Lepidium apetalum Willd Protect NRK52e Cells against Hypertonic-Induced Adhesion and Inflammation by Suppressing the MAPK Signaling Pathway and RAAS.

Authors:  Peipei Yuan; Xiaoke Zheng; Meng Li; Yingying Ke; Yang Fu; Qi Zhang; Xiaolan Wang; Weisheng Feng
Journal:  Molecules       Date:  2017-11-12       Impact factor: 4.411

3.  Luhong Formula Has a Cardioprotective Effect on Left Ventricular Remodeling in Pressure-Overloaded Rats.

Authors:  Qian Liu; Hui-Yan Qu; Hua Zhou; Jing-Feng Rong; Tian-Shu Yang; Ji-Jie Xu; Xiao-Li Yang; Zhen-Zhen Lan
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-30       Impact factor: 2.629

4.  Clinical Prescription-Protein-Small Molecule-Disease Strategy (CPSD), A New Strategy for Chinese Medicine Development: A Case Study in Cardiovascular Diseases.

Authors:  Yong-Zhi Guo; Ying-Nan Jiang; Yi-Fang Li; Hiroshi Kurihara; Yi Dai; Rong-Rong He
Journal:  Front Pharmacol       Date:  2020-01-22       Impact factor: 5.810

5.  NDRG4 Alleviates Myocardial Infarction-Induced Apoptosis through the JAK2/STAT3 Pathway.

Authors:  Changliang Zhao; Yuanyuan Ren; Yachao Zhang
Journal:  Comput Math Methods Med       Date:  2022-01-27       Impact factor: 2.238

6.  Gypenosides ameliorate high-fat diet-induced non-alcoholic steatohepatitis via farnesoid X receptor activation.

Authors:  Hongshan Li; Yingfei Xi; Hongliang Liu; Xin Xin
Journal:  Front Nutr       Date:  2022-08-24

7.  Gypenosides regulate farnesoid X receptor-mediated bile acid and lipid metabolism in a mouse model of non-alcoholic steatohepatitis.

Authors:  Hongshan Li; Yingfei Xi; Xin Xin; Huajie Tian; Yiyang Hu
Journal:  Nutr Metab (Lond)       Date:  2020-05-01       Impact factor: 4.169

8.  Luhong Granules Prevent Ventricular Remodelling after Myocardial Infarction by Reducing the Metabolites TMAO and LPS of the Intestinal Flora.

Authors:  Tianshu Yang; Huiyan Qu; Xiaolong Song; Qian Liu; Xiaoli Yang; Jijie Xu; Tao Yang; Zhenzhen Lan; Wanjing Sha; Hua Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-16       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.